Search results for "Coronary"

showing 10 items of 1588 documents

Prevalence of distress, comorbid conditions and well being in the general population.

2011

Abstract Background The purposes of this paper are to determine the prevalence of distress in the community, to identify its determinants and to assess its relationship to somatic conditions and subjective well being. Methods Distress and associated factors were investigated in a random sample of 5000 participants (35–74 years) of a community-based, prospective, observational cohort study in western Mid-Germany (“Gutenberg Heart Study”) between 04/2007 and 10/2008. The sample was stratified 1:1 for gender and residence and in equal strata for decades of age. Data were assessed by self-report instruments, interviews and medical examination. Results We found a prevalence rate for depression o…

AdultMalemedicine.medical_specialtyPopulationMyocardial InfarctionCoronary DiseaseComorbidityAnxietyPersonality DisordersMental distressResidence CharacteristicsGermanymedicineDiabetes MellitusPrevalenceHumansObesityProspective StudiesPsychiatryeducationDepression (differential diagnoses)AgedDyslipidemiaseducation.field_of_studyDepressionType D personalitySocial anxietyMiddle AgedStrokePsychiatry and Mental healthClinical PsychologyDistressMental HealthHypertensionAnxietyPanic DisorderFemalemedicine.symptomPsychologyStress PsychologicalCohort studyJournal of affective disorders
researchProduct

Barriers to physical activity in coronary artery disease patients: Development and validation of a new scale

2017

Abstract Objective To develop and validate a self-report questionnaire to measure barriers to regular physical activity (PA) in patients with stable coronary artery disease (CAD). Methods Phase 1: 17 patients completed a semi-structured interview. After grouping and reformulating the reported barriers, their pertinence was reevaluated by the patients. Then, a decision algorithm was used to select items. A principal component analysis was performed to determine content validity. Phase 2: 49 patients completed the questionnaire resulting from phase 1 twice, 7 days apart, and questionnaires to evaluate depression, anxiety, and the level of physical activity. Construct validity was evaluated by…

AdultMalemedicine.medical_specialtyPsychometricsNeuropsychological Tests030204 cardiovascular system & hematologyCoronary artery diseaseStatistics NonparametricValidityYoung Adult03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemCronbach's alphamedicineContent validityHumansOrthopedics and Sports MedicineProspective cohort studyExerciseReliability (statistics)Face validityPrincipal Component AnalysisPhysical activityQuestionnairebusiness.industryRehabilitationReproducibility of ResultsConstruct validity[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemReliabilityScale (social sciences)Physical therapyAnxietyFemaleSelf Reportmedicine.symptombusinessBarriers030217 neurology & neurosurgeryAnnals of Physical and Rehabilitation Medicine
researchProduct

Cardioprotective Effects of the Na + /H + Exchange Inhibitor Cariporide in Patients With Acute Anterior Myocardial Infarction Undergoing Direct PTCA

2000

Background —Activation of Na + /H + exchange in myocardial ischemia and/or reperfusion leads to calcium overload and myocardial injury. Experimental studies have shown that Na + /H + exchange inhibitors can attenuate Ca 2+ influx into cardiomyocytes. We therefore performed a multicenter, randomized, placebo-controlled clinical trial to test the hypothesis that inhibition of Na + /H + exchange limits infarct size and improves myocardial function in patients with acute anterior myocardial infarction (MI) treated with direct PTCA. Methods and Results —One hundred patients were randomized to receive placebo (n=51) or a 40-mg intravenous bolus of the Na + /H + exchange inhibitor cariporide (HOE…

AdultMalemedicine.medical_specialtySodium-Hydrogen Exchangersmedicine.medical_treatmentMyocardial InfarctionPlaceboGuanidinesVentricular Function LeftLesionchemistry.chemical_compoundPhysiology (medical)AngioplastyInternal medicinemedicineHumansCardioprotective AgentSulfonesMyocardial infarctionAngioplasty Balloon CoronaryAgedChemotherapybiologyCariporidebusiness.industryMyocardiumHeartMiddle Agedmedicine.diseaseTreatment OutcomechemistryAnesthesiabiology.proteinCardiologyFemaleCreatine kinasemedicine.symptomCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Advantages of immediate two-dimensional echocardiography in patients with acute cardiac ischemic events

1995

Abstract We hypothesized that the assessment of kinetic alterations on two dimensional echocardiogram (2DE) would provide greater diagnostic information than clinical symptoms and ECG changes only. The study was aimed to determine sensitivity of 2DE in patients with cardiac ischemic events and to improve the indications to thrombolysis. Three-hundred ninety-one patients (87 F; 304 M) hospitalized for suspected acute myocardial infarction (AMI), first episode, within 4 h from the onset of symptoms, suitable for thrombolysis Killip class I–II and with unstable angina (UA), were admitted in the study. Patients had to show ECG changes and alterations of segmentary motion on 2DE performed at ent…

AdultMalemedicine.medical_specialtySystolemedicine.medical_treatmentMyocardial InfarctionMyocardial IschemiaIschemiaInfarctionSensitivity and SpecificityVentricular Function LeftElectrocardiographyFibrinolytic AgentsInternal medicinemedicineHumansThrombolytic TherapyAngina Unstablecardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassCreatine KinaseAgedKillip classAged 80 and overFirst episodeHeparinVascular diseaseUnstable anginabusiness.industryThrombolysisMiddle Agedmedicine.diseaseIsoenzymesSurvival RateEchocardiographyVentricular Function RightCardiologyFemaleCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Usefulness of concomitant myoglobin and troponin elevation as a biochemical marker of mortality in non–ST-segment elevation acute coronary syndromes

2003

Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703–1708. 2. Senior R, Kaul S, Soman P, Lahiri A. Power-Doppler contrast echocardiography—a new technique for Assessing myocardial perfusion. Am Heart J 2000; 139:245–251. 3. Picano E, Parodi O, Lattanzi F, Sambuceti G, Andrade MJ, Marzullo P, Giorgetti A, Salvadori P, Marzilli M, Distante A. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography. Circulation 1994;89:753–761. 4. Jayaweera AR, Wei K, Coggins M, Bin…

AdultMalemedicine.medical_specialtyTime FactorsCoronary DiseaseFractional flow reserveSensitivity and SpecificityHospitals UniversityCoronary artery diseaseElectrocardiographyRisk FactorsCause of DeathInternal medicineSpect imagingHumansMedicineFalse Positive ReactionsHospital MortalityAgedAged 80 and overAnalysis of VariancebiologyMyoglobinbusiness.industryMiddle AgedPrognosismedicine.diseaseTroponinTroponinDipyridamolemedicine.anatomical_structureCoronary stealSpainbiology.proteinCardiologyFemaleTriageCardiology and Cardiovascular MedicinebusinessPerfusionBiomarkersArterymedicine.drugThe American Journal of Cardiology
researchProduct

Short-Term Prognosis of Juvenile Myocardial Infarction

2016

In our early research regarding the hemorheological pattern in patients with acute myocardial infarction (AMI) with a mean age of 61.45 + 10.99 years, we showed that the major hemorheological parameters were almost normalized 2 weeks after the acute event. In the last decade, we focused on hemorheological parameters in juvenile myocardial infarction (JMI), defined as AMI in patients aged 45 years, in the ‘‘Sicilian study on juvenile myocardial infarction’’. Juvenile myocardial infarction is responsible for 2% to 10% of all cases with AMI in different surveys. Juvenile myocardial infarction presents a typical pattern of risk factors and shows clinical, angiographic, and prognostic characteri…

AdultMalemedicine.medical_specialtyTime FactorsIschemic heart diseaseBlood viscosity030204 cardiovascular system & hematologyBlood rheology030218 nuclear medicine & medical imagingAnginaCoronary artery diseasePlasma03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal medicinemedicineHumansMyocardial infarctionAge of OnsetRisk factorNon-ST Elevated Myocardial InfarctionBlood rheology; Myocardial infarction; Ischemic heart diseaseMedicine (all); Cardiology and Cardiovascular Medicinebusiness.industryMedicine (all)HemodynamicsBlood ViscosityPrognosismedicine.diseaseMyocardial infarctionHeart failureCoronary vesselDisease ProgressionCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessAngiology
researchProduct

Prognostic Value of a Comprehensive Cardiac Magnetic Resonance Assessment Soon After a First ST-Segment Elevation Myocardial Infarction

2009

ObjectivesTo evaluate the prognostic value of a comprehensive cardiac magnetic resonance (CMR) assessment soon after a first ST-segment elevation myocardial infarction (STEMI).BackgroundCMR allows for a simultaneous assessment of wall motion abnormalities (WMA), WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI. Its prognostic value and the relative prognostic weight of these indexes are not well-defined.MethodsWe studied 214 consecutive patients with a first STEMI treated with thrombolytic therapy or primary angioplasty discharged from hospital. In …

AdultMalemedicine.medical_specialtyTime FactorsMagnetic Resonance Imaging CineInfarctionKaplan-Meier EstimateRisk Assessmentcardiac magnetic resonanceNecrosisPredictive Value of TestsRecurrenceRisk FactorsDobutamineInternal medicinemedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsHeart Failurebusiness.industryMyocardiumAdrenergic beta-AgonistsMiddle Agedmedicine.diseaseCoronary VesselsMyocardial ContractionTreatment Outcomemyocardial infarctionRadiology Nuclear Medicine and imagingHeart failureMicrovesselscardiovascular systemCardiologyMyocardial infarction complicationsFemaleDobutamineprognosisMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessTIMIMacemedicine.drugJACC: Cardiovascular Imaging
researchProduct

Immediate versus delayed facilitated percutaneous coronary intervention. A pilot study

2005

The study was aimed to investigate the outcomes in patients initially successfully treated pharmacologically and immediate PCI <2 hours, and in patients initially successfully treated with pharmacological therapy and delayed PCI (12-72 hours). All patients had to have successful reperfusion, to receive the combination of a standard abciximab infusion plus half dose rtPA. Similar results were observed in both groups. Delayed PCI group showed a favorable trend in restenosis and bleedings (ns) and a significant reduced angiographic evidence of thrombus formation in IRA. Our very preliminary data suggest the safety and possible use of delayed facilitated PCI in patients with STEMI. The studied …

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAbciximabMyocardial InfarctionMyocardial IschemiaEligibility DeterminationMyocardial ReperfusionPilot ProjectsAcute myocardial infarctionElectrocardiographyImmunoglobulin Fab FragmentsRestenosisInternal medicinemedicineAbciximabHumansIn patientcardiovascular diseasesThrombusAngioplasty Balloon CoronaryFacilitated pciDelayed percutaneous coronary interventionPharmacologybusiness.industryPatient SelectionPercutaneous coronary interventionAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival RateGIIb/IIIa inhibitorssurgical procedures operativeTreatment OutcomeTissue Plasminogen ActivatorConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessFacilitated percutaneous coronary interventionTIMIPlatelet Aggregation InhibitorsCombined therapymedicine.drug
researchProduct

Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz …

1991

OBJECTIVE--Intracoronary stenting was designed to overcome acute complications after percutaneous transluminal coronary angioplasty and to achieve a reduced rate of restenosis, both of which are major limitations of this well accepted method for treating coronary heart disease. This report describes the experience at one centre with the implantation of balloon-expandable Palmaz-Schatz stents and focuses on device related complications and the short and long term angiographic outcome. DESIGN--A retrospective data analysis. PATIENTS--Stenting was attempted in 50 patients. Restenosis after an initially successful angioplasty procedure, inadequate postangioplasty results, saphenous coronary byp…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentArterial Occlusive DiseasesCoronary DiseaseBalloonCoronary AngiographyCoronary thrombosisRestenosisRecurrenceAngioplastymedicineHumansThrombusAngioplasty Balloon CoronaryAgedRetrospective Studiesbusiness.industryCoronary ThrombosisStentThrombolysisMiddle Agedmedicine.diseaseSurgeryBypass surgeryFemaleStentsRadiologyCardiology and Cardiovascular MedicinebusinessResearch Article
researchProduct

New balloon catheter for prolonged percutaneous transluminal coronary angioplasty and bypass flow in occluded vessels.

1986

A new balloon catheter was developed for continuous perfusion of coronary arteries during angioplasty (CPC catheter). Steerable Gruntzig balloon catheters (3.7 mm) with two lumina were formed. The first lumen was used for balloon inflation. Side holes to the second lumen proximally and distally to the balloon were created for coronary perfusion even during inflation phase. At a perfusion pressure of 120 mmHg, a flow rate of 63 +/- 3 ml/min with 0.9% saline and 43 +/- 1 ml/min with plasma expander were measured. In experiments on five dogs, dilation time until appearance of signs of ischemia could be prolonged in three of five dogs from 30 to 40 s, 120 to 203 s, and 180 to 420 s comparing co…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentLumen (anatomy)Arterial Occlusive DiseasesCoronary DiseaseBalloonAnginaDogsAngioplastyInternal medicineMedicineAnimalsHumansbusiness.industryBalloon catheterMiddle Agedmedicine.diseaseSurgeryCoronary arteriesPerfusionCathetermedicine.anatomical_structureCoronary vesselCardiologyRegression AnalysisCardiology and Cardiovascular MedicinebusinessAngioplasty BalloonCatheterization and cardiovascular diagnosis
researchProduct